Objective: To establish that human adipocytes express functional glucose-dependent insulinotropic peptide (GIP) receptors and in particular the regulation of GIP receptor (GIPR) expression in the context of the dynamic process of adipocyte differentiation. Design: A combination of semiquantitative real-time PCR and measurement of GIP-stimulated cAMP accumulation was used to establish the expression and functional coupling of GIPRs during in vitro differentiation of human Simpson-Golabi-Behmel syndrome (SGBS) preadipocytes. Results: Semiquantitative real-time PCR revealed that GIPR expression was substantially increased by day 4 of differentiation, reaching a maximum around 6-8 days (B200-fold increase above undifferentiated cells, n ¼ 2). We also analysed the expression of the adipocyte fatty acid binding protein (FABP4) to relate GIPR expression to a molecular differentiation marker of adipogenesis. FABP4 expression was barely detectable in undifferentiated cells. However, following exposure to adipogenic medium, FABP4 expression gradually increased, with a maximal expression level around 10 days (B1 600 000-fold increase above undifferentiated cells, n ¼ 2). Thus, the increases in GIPR mRNA during adipogenesis occur earlier than FABP4, suggesting that it might represent a gene expressed early in terminal differentiation and thus plays a role in fat droplet formation. A unit of 1 mM GIP failed to raise intracellular cAMP levels above basal levels in undifferentiated cells (n ¼ 3). In stark contrast, the 9-day differentiated cells produced a robust concentration-dependent increase in cAMP accumulation following stimulation with GIP, with an EC 50 value of 2.3 nM (n ¼ 3). The maximal response represented a 9-34-fold increase in cAMP accumulation above basal levels. Conclusions: This study demonstrates that GIPRs are expressed by human adipocytes, both GIPR mRNA and functional receptor expression being present in differentiated adipocytes but not in preadipocytes. Further investigation into the functional effects of GIP on differentiated SGBS cells could help towards understanding exactly how GIP regulates fat accumulation in human adipocytes.
Introduction
Incretins are peptide hormones that originate in the gastrointestinal tract and are released during nutrient absorption, augmenting glucose-dependent insulin secretion from pancreatic b-cells. The two major incretins in humans are glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP). In a study using antagonists for the GLP1 and GIP receptors (GIPRs), it was shown that GIP is the major physiological incretin, contributing to 80% of the incretin-induced insulin release. 1 GIP is a 42-amino-acid peptide secreted by the lymphocyte K cells, which are located within the intestinal epithelium of the proximal deuodenum and is primarily regulated by ingestion of glucose or fat. 2, 3 The molecular mechanisms whereby GIP potentiates glucosedependant insulin secretion by b-cells include increases in cAMP, inhibition of K ATP channels, increases in intracellular Ca 2 þ and stimulation of exocytosis. 4 There is increasing evidence that as well as its effects on blood glucose control; GIP also has a function in lipid metabolism and the development of obesity and diabetes.
Functional GIPRs are expressed on isolated rat adipocytes and 3T3-L1 cells and have been shown to increase cAMP levels, stimulate lipoprotein lipase activity and promote fatty acid incorporation in the presence of insulin. [5] [6] [7] [8] The importance of GIP signalling on fat accumulation in vivo was first reported in mice with a targeted disruption of the GIPR. 7 In wild-type mice fed with a high-fat diet, insulin resistance, hypersecretion of GIP and extreme fat deposition was seen, whereas GIPR (À/À) mice fed with high-fat diet were protected from both obesity and insulin resistance. The role of GIP in obesity is further supported by results from double-homozygous mice (GIPR
, ob/ob) that exhibited less weight gain, reduced adiposity and improved glucose tolerance and insulin sensitivity relative to ob/ob mice. 7 A similar response was also observed when ob/ob mice were treated daily with a stable GIPR antagonist, (Pro 3 )GIP. 9 (Pro 3 )GIP has also been reported to protect against obesity, insulin resistance, glucose intolerance and associated metabolic disturbances in mice fed with high-fat diets, 10 and protect ob/ob mice from developing diabetes.
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The GIPR belongs to the seven transmembrane helix family of G-protein-coupled receptors and is widely distributed in peripheral tissues and several regions in the central nervous system. 12, 13 Expression of the GIPR has previously been reported in isolated rat adipocytes by a combination of RNAse protection and western blott analysis. 6 It has also been reported in differentiated 3T3-LI cells, an established cell-line model for adipocytes, using reverse transcriptase PCR, RNAse protection, western blott analysis, radioligandbinding and functional assays measuring glycerol release and cAMP accumulation. 6, 14 However, of particular interest to this study was the observation that undifferentiated 3T3-L1 cells did not appear to express the GIPR. 6 This led us to speculate that the expression of the GIPR in humans might be dependent on the differentiation of adipocytes. There are no reports of GIPR expression relating to isolated human adipocytes and in particular the regulation of GIPR expression in the context of the dynamic process of adipocyte differentiation. A recent report has, however, identified GIPR mRNA expression in subcutaneous and visceral adipose tissues from non-diabetic postmenopausal women. 13 The object of this study was, therefore, to analyse and characterize how expression of the GIPR and functional coupling to adenylate cyclase relates to the differentiation process of human adipocytes. For this purpose, we used the recently established in vitro model of Simpson-GolabiBehmel syndrome (SGBS) human preadipocytes, a cell strain, which has the capacity to differentiate into mature adipocytes under defined experimental conditions. 15 Oil Red O staining Cells were stained with Oil Red O, using a modification of the method described by Janderova et al. 17 Briefly, cells cultured in 25-cm 2 flasks were fixed in a 10% solution of formaldehyde in phosphate-buffered saline for 5 min at room temperature, washed with 60% isopropanol and stained with Oil Red O solution (in 60% isopropranol) for 10 min followed by repeated washing with water (4 times with 10 ml). Stained cells were immediately viewed under phase contrast using an Olympus CKX41 inverted microscope and images captured using a mounted Olympus C-5060 digital camera.
Materials and methods

Materials
Total RNA isolation and real-time reverse transcriptase PCR Real-time PCR was used to measure the adipocyte fatty acid binding protein (FABP4) and GIPR gene expression levels in SGBS cells. Over a time course from undifferentiated to 14 days differentiation, total RNA was isolated from a 25-cm 2 flask every 2 days, starting at day 0, using 2 ml of TRIzol
Human adipocytes express functional GIP receptors RE Weaver et al reagent following the manufacturer's instructions. Yield and purity were determined using a NanoDrop ND-1000 spectrophotometer. Reverse transcription was carried out using a TaqMan Reverse Transcription Kit, in a final volume of 25 ml containing 500 ng of total RNA, 2.6 mM random hexamers, 2 mM dNTPs, 10 U RNase inhibitor, 5.5 mM MgCl 2 , 30U MultiScribe reverse transcriptase and 2.5 ml of 10 Â RT buffer. An initial denaturation step at 65 1C for 5 min was followed by 4 1C for 1 min (RNA and random hexamers only). The remaining reagents were then added and the reaction incubated at 25 1C for 10 min, 48 1C for 50 min, and then stopped by heat inactivation at 95 1C for 5 min. The resulting cDNA product was then made up to 60 ml with H 2 O and stored at À30 1C until analysis by real-time PCR. Real-time quantitative PCR was performed with an ABI 7900HT Sequence Detection System (Applied Biosystems) using the TaqMan Universal PCR Master Mix protocol. Primers and TaqMan probes for the human FABP4 and GIPR gene were obtained from the Applied Biosystems as a TaqMan Gene Expression Assays (assay IDs Hs00609210_m1 and Hs00609791_m1, respectively). Forward and reverse primers for human glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (GCTCCTCCTGTTCGACAGTCA and ACCT TCCCCATGGTGTCTGA, respectively) were obtained from Invitrogen. The TaqMan probe for human GAPDH (VIC-TTCTTTTGCGTCGCCAGCCGAG-TAMRA) was custom synthesized by Applied Biosystems. All primer sets were designed to be located in two exons to avoid the amplification of potentially contaminating genomic DNA. All reactions (in triplicate) were performed in a 25-ml final volume containing 2 ml of the cDNA product, 12.5 ml of TaqMan 2 Â universal PCR Mastermix and either 1.25 ml of the 20 Â TaqMan gene expression assay mastermix for FABP4 and GIPR or 100 nM of both forward primer and TaqMan probe plus 300 nM of reverse primer for GAPDH. The PCR cycling parameters were set as follows: 95 1C for 10 min followed by 40 cycles of 95 1C for 15 s and 60 1C for 1 min. Non-template controls were included to ensure specificity. FABP4 and GIPR mRNA levels were normalized to the values of the endogenous control GAPDH, and the results expressed as relative fold changes using the 2 ÀDDCT method. 18 Data presented are the mean values of two independent experiments.
Assay of cAMP accumulation in SGBS cells
The measurement of intracellular levels of cAMP was performed as previously described by Balmforth et al.
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Briefly, six-well plate containing cells were incubated in 2 ml of DMEM/F12 (1:1), containing [
), for 2 h at 37 1C in a humidified atmosphere. The cells were then washed with DMEM F12 (2 Â 2 ml). Next, 2 ml of DMEM/F12 containing 0.1 mM IBMX (3-isobutyl-1-methylxanthine) and either GIP or forskolin was added to the cells in each well and incubated for 12 min at 37 1C. The drug solution was then aspirated and 1.5 ml of ice cold 5% trichloroacetic acid, containing 2.5 nCi ml À1 of [ 
Statistical analysis of results
Concentration-response curves for GIP were studied in 9-day differentiated SGBS cells. For each independent experiment (n ¼ 3), cAMP responses were averaged from triplicate determinations, once mean basal responses had been subtracted at each agonist concentration datapoint. Data were then plotted and analysed as a Log concentration-response curve using a non-linear regression program (GraphPAD Prism software) to establish the EC 50 value and the maximal agonist response. All data are presented as the mean ± s.e.m.
(n ¼ 3), unless otherwise stated. Statistical analysis was conducted on data presented in Figure 3 using an unpaired Student's t-test; Po0.05 was considered statistically significant.
Results
Confluent SGBS cells, before incubation in adipogenic medium, displayed a fibroblast-like preadipocyte morphology ( Figure 1a) . Following induction of differentiation, cells became enlarged and increasingly accumulated small lipid droplets. This was readily observable by day 5 ( Figure 1b) . As differentiation continued, the cells developed into typical multiocular lipid-filled adipocytes (readily observed by 7-8 days), with over 90% of cells differentiated by day 14 ( Figure 1c ). Oil Red O staining confirmed the storage of lipids in mature adipocytes (Figure 1d ), but not in undifferentiated adipocytes (data not shown). Semiquantitative real-time PCR analysis of total RNA isolated from SGBS cells between 0-14 days following exposure to adipogenic conditions revealed increased expression of the GIPR (Figure 2 ). Data are represented as a relative percentage fold increase above undifferentiated gene expression levels, which was barely detectable (0.4%; C T value 36, suggesting relatively few copies per cell). GIPR expression was substantially increased by day 4 of differentiation, reaching a maximum around days 6-8 (B200-fold increase above undifferentiated cells). From days 8 to 14 of differentiation, GIPR expression gradually decreased to B50% of the maximum observed on day 6. We also analysed the expression of the adipocyte fatty acid binding protein (FABP4) to relate GIPR expression to a molecular differentiation Human adipocytes express functional GIP receptors RE Weaver et al marker of adipogenesis. FABP4 expression was at the extreme level of detection in undifferentiated SGBS cells (C T value 38, suggesting one or two copies per cell). However, following the exposure to adipogenic medium, FABP4 expression gradually increased with a maximal expression level around 10 days (B1 600 000-fold increase above undifferentiated cells), which remained at that level for the remaining 4 days of the differentiation time course (Figure 2) .
The GIPR is functionally coupled to the stimulation of adenylate cyclase, resulting in an increase in intracellular cAMP levels. 6, 12 Incubation of undifferentiated SGBS cells with 1 mM forskolin (a direct activator of adenylate cyclase) for 12 min led to a 2.5-fold increase above basal (cAMP accumulation in the absence of drug) accumulation of intracellular cAMP (Figure 3 ). However, incubation of these undifferentiated cells with 1 mM GIP failed to raise intracellular cAMP levels above basal levels. These data are in keeping with the barely detectable levels of GIPR mRNA expression. In stark contrast, 9-day differentiated SGBS cells produced a robust concentration-dependent increase in cAMP accumulation following stimulation with GIP. Day nine was chosen, as it represented a convenient time at which the cells were well differentiated and also expressed maximal levels of GIPR mRNA. The concentration-response curve was sigmoidal in shape, with an EC 50 value (the concentration of agonist required to achieve 50% of the maximal response) of 2.3 ± 0.5 nM (n ¼ 3) and a maximal response estimated to occur at concentrations of 1 mM and above ( Figure 4 ). The maximal response represented a 9-34-fold increase in cAMP accumulation above basal levels.
Discussion
Human SGBS preadipocytes, originally derived from the stromal fraction of subcutaneous adipose tissue of an infant with SGBS are a cell strain with high capacity for adipose differentiation in serum-free medium. 15 A number of studies have established that the pattern and time-course of gene expression in SGBS cells during differentiation is comparable to the findings in human preadipocytes in primary culture and also resemble the characteristics of rodent preadipocyte cell lines such as 3T3-L1, 3T3-F442A and ob17. 15, 16, [20] [21] [22] [23] [24] Differentiated SGBS cells also behave biochemically and functionally like human adipocytes differentiated in primary culture. 15, 16, 25 In this study, we used these cells to examine the regulation of GIPR expression in the context of the dynamic process of adipocyte differentiation. Human adipocytes express functional GIP receptors RE Weaver et al
The progression of differentiation of 3T3-L1 is well documented and involves four recognized stages of gene expression (for review, see Avram et al. 24 ). The fourth stage, which occurs during terminal differentiation (day 4 of induced differentiation onwards) and is associated with fat droplet formation, involves the expression of genes implicated in glucose and lipid metabolism. For example, there are increases in cell surface receptors and transporters, including the insulin receptor and the glucose transporter GLUT4, which make adipocytes more sensitive to insulin. Another well-documented gene, which is expressed in a differentiation-dependent fashion and is therefore considered an adipogenic marker is adipocyte fatty acid-binding protein, FABP4 (also known as ALBP and aP2).
The adipocyte fatty acid-binding protein, FABP4 is a low molecular weight (15 kDa) abundant protein that forms 1:1 complexes with fatty acids, retinoids and other hydrophobic ligands in adipocytes. FABP4 is believed to have two functions in lipolysis. 26 The first is to facilitate free fatty acid diffusion from the site of hydrolysis (lipid droplet) to the plasma membrane, as part of lipid efflux from the cell. The second is to attenuate hormone sensitive lipase activity with which it interacts on the surface of the lipid droplet. Differentiation studies in 3T3-L1 cells have reported that the expression of mRNA for FABP4 is absent in undifferentiated cells, is detectable by day 3 of differentiation and then rapidly increases towards a steady state around day 8 (several 100-fold increase in gene expression), for up to 28 days. 20, 22, 27 Similar profiles of FABP4 gene expression have been observed during the differentiation of human marrow and adipose tissue stromal cells into adipocytes, 28, 29 as well as during the differentiation of SGBS cells. 16 We specifically analysed the expression profile of FABP4 during the differentiation of SGBS cells to relate GIPR expression to a well-established molecular differentiation marker of adipogenesis. Using semiquantitative real-time PCR, we observed a time profile of differentiation-induced FABP4 expression, similar to the above studies, however, the increase in expression at steady state (around day 10) was several orders of magnitude higher than that observed in undifferentiated SGBS cells (possibly one or two copies per cell).
In this study, we report, for the first time, that GIPR mRNA and functional expression on the cell surface is dependant and GIPR gene expression levels during differentiation of SGBS cells. Total RNA was extracted from a 25-cm 2 flask of differentiating SGBS cells over a 0-14-day period every 2 days, starting at day 0, and gene expression measured using semiquantitative real-time PCR, with simultaneous amplification of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as an internal control allowing normalization of target expression levels. Data represent the mean values observed in two independent experiments where each datapoint was originally assayed in triplicate. To allow direct comparison, normalized expression data for each gene was converted to percentage fold gene expression, with 100% FABP4 representing a 1 637 506-fold and GIPR representing a 209-fold increase in levels measured in undifferentiated SGBS cells (day 0). GIPR, glucose-dependent insulinotropic peptide receptor; SGBS, Simpson-Golabi-Behmel syndrome. Human adipocytes express functional GIP receptors RE Weaver et al on the differentiation of human adipocytes in vitro. In keeping with earlier work on 3T3-L1 cells, 6 we found no evidence of expression of functional GIPRs by preadipocytes (undifferentiated SGBS cells). However, following the exposure of preadipocytes to adipogenic medium, there was a substantial increase in mRNA, which peaked around 6-8 days of differentiation (B200-fold increase above undifferentiated cells). GIPR mRNA expression then gradually decreased to B50% of the maximum observed on day 6. Compared to the time course of the adipogenesis marker, FABP4, two observations were made. The first was that increases in GIPR mRNA during adipogenesis occur earlier than FABP, suggesting that it might represent a gene expressed early in terminal differentiation and thus have a function in fat droplet formation. The second was that, unlike FABP4 expression, which attained a steady state, GIPR mRNA expression decreased as the differentiated cells continued to store triglycerides. Whether this relates to the recent observation that GIPR mRNA expression is attenuated in subcutaneous adipose tissue of women with central obesity remains to be determined. 13 To investigate whether the GIPR gene expression levels correlated with the expression of functional GIPRs on the cell surface, both undifferentiated and differentiated SGBS cells were assayed for GIP-dependant cAMP accumulation. Previous studies of 3T3-L1 cells established that the incubation of differentiated cells with 10 nM GIP produced a fourfold increase in cAMP accumulation, whereas there was no increase in undifferentiated cells. 6 Identical findings were observed in undifferentiated SGBS cells where stimulation with 1 mM GIP produced no increase in cAMP accumulation. Inclusion of a positive control (1 mM forskolin) established the validity of this finding. However, functional GIPRs were observed in 9-day differentiated SGBS cells and a sigmoidal concentration-response curve was established. cAMP accumulation was maximal at 1 mM GIP (9-34-fold increase in cAMP accumulation above basal levels), with an EC 50 value of 2.3 nM. This value compares favourably with previous reports of GIP-stimulated cAMP accumulation in Chinese hamster lung fibroblasts stably transfected with the human GIPR (EC 50 vaules between 0.5 and 3.6 nM) [30] [31] [32] and also with GIP-mediated glycerol release from the differentiated 3T3-L1 cells (EC 50 value 3.3 nM).
14 Studies of the effects of GIP on adipocyte metabolism have shown what appear to be conflicting results. A direct lipogenic role has been suggested from the observations that GIP stimulates glucose transport and increased fatty-acid synthesis in isolated adipocytes, 33 and both lipoprotein lipase activity and fatty-acid synthesis in fat tissue are enhanced in the presence of GIP. 34 The physiological importance of these effects was emphasized by the finding that GIPR knockout mice fed with a high-fat diet were protected from both obesity and insulin resistance. 7 Furthermore, this result was reproduced by daily treatment of normal mice fed with high-fat diets with a stable GIPR antagonist, (Pro 3 )GIP. 10 However, in differentiated 3T3-L1 cells, GIP has been reported to behave as a lipolytic hormone, as it was observed to stimulate glycerol release through the activation of adenylate cyclase. 14 Interestingly, the effect of GIP was inhibited by the coincubation of insulin, suggesting that the response of the adipocyte to GIP may depend upon the prevailing circulating insulin level. It also raised the possibility that the lipogenic effects of GIP might involve other pathways. During the development of this study, a new signal transduction pathway utilized by GIP and involved in increasing fat storage in adipocytes was reported in differentiated 3T3-L1 cells. 8 Further investigation of the slow time of onset of this response led to the conclusion that the activation of lipoprotein lipase stimulated by GIP was indirect and involved GIP-mediated secretion of the adipokine resistin. 35 This study demonstrates, using SGBS cells in culture, that the GIPR is expressed by human adipocytes, both GIPR mRNA and functional receptor expression being present in differentiated adipocytes but not in preadipocytes. The finding of differentiation-dependent regulation of the GIPR, with expression levels rising as the differentiating preadipocyte begins to accumulate lipid droplets, is in keeping with the previous proposal regarding the enteroadipocyte axis and that circulating levels of GIP directly links overnutrition to obesity. 7 Considering the potential of GIPR antagonists in the treatment of obesity and type 2 diabetes, it is surprising that there are no previous studies examining the expression and functional signalling of GIPRs in human adipocytes. Unlike rodents, most previous reports of human adipocytes, including differentiated SGBS cells, have found no conclusive evidence of resistin expression or secretion. 16, [36] [37] [38] Consequently, it is unlikely that GIP regulates fat accumulation in human adipocytes by activating lipoprotein lipase through a mechanism involving GIP-mediated secretion of resistin. Further investigation into the functional effects of GIP on differentiated SGBS cells could help towards understanding exactly how GIP regulates the fat accumulation in human adipocytes.
